en/ayurveda – 21. oldal
- Ayurveda in 2025: Sustainability, Institutions, and the Rise of AI-Enabled Care 2026-02-04
A 2025 snapshot of Ayurveda’s evolution: stronger institutions, a sustainability-focused public-health message, and emerging AI applications that may reshape how traditional knowledge is delivered and studied.
- Health & Ayurveda in 2026: Gut Immunity, Sustainable Living, and the Rise of AI 2026-02-04
A practical overview of how Ayurveda is being discussed in India today—from winter gut-health routines and immunity to sustainable healthcare and emerging AI-enabled Ayurveda.
- Giloy in Ayurveda: Benefits, Safe Use, and Why It’s Back in the Spotlight 2026-02-03
Giloy (Tinospora cordifolia) is a classic Ayurvedic herb widely discussed for immunity and resilience. Learn its traditional benefits, practical ways to use it safely, and how India’s renewed AYUSH focus is shaping Ayurveda’s future.
- India’s Push to Become a Global Hub for Medical Tourism, Biopharma and Ayurvedic Medicines 2026-02-03
India is positioning itself as a leading destination for medical tourism and a manufacturing base for biopharma and Ayurvedic products. This article explains what that shift could mean for quality, access, regulation, and safe use of Ayurveda in wellness and healthcare travel.
- Ayurveda in India: What It Is, How It Works, and How to Experience It Safely 2026-02-03
A practical overview of Ayurveda in India—its core principles, common therapies, and how to choose authentic, safe experiences as a visitor.
- Biopharma Shakti and Ayurveda: What India’s Biologics Push Could Mean for Health 2026-02-03
India’s Biopharma Shakti mission aims to strengthen complex biologics manufacturing. Here’s how this shift can intersect with Ayurveda, quality standards, and patient trust in integrative health.
- Union Budget 2026: Ayurveda, Advanced Care, and India’s Bid to Lead Global Health Travel 2026-02-03
India’s Union Budget 2026 signals a health strategy that links Ayurveda, modern tertiary care, and biopharma manufacturing to attract global patients. Here’s what it could mean for Ayurveda’s role in health travel and credibility.
- India’s Budget 2026-27 Push for Ayurveda: New Institutes, Regional AYUSH Hubs, and What It Means for Health Care 2026-02-02
India’s 2026-27 budget announcements signal a major expansion of Ayurveda and the wider AYUSH ecosystem through new institutes, regional hubs, and pharmacy upgrades. Here’s what that could mean for education, access, quality, and evidence in integrative health care.
- India’s Budget 2026 Push: New Ayurveda Institutes, AYUSH Upgrades and a Biopharma Mission 2026-02-02
India’s Union Budget 2026 signals a stronger national push for Ayurveda and the wider AYUSH ecosystem, alongside a major biopharma strategy and medical-tourism ambitions. Here’s what was announced and what it could mean for health, training, and care delivery.
- India’s Budget 2026 Push for Ayurveda: Three New All India Institutes and a Stronger AYUSH Ecosystem 2026-02-02
India’s Union Budget 2026–27 signals a major capacity-building move for Ayurveda and the wider AYUSH ecosystem by proposing three new All India Institutes of Ayurveda alongside broader healthcare innovation priorities.